Prolonged Administration of the KCa Channel Activator SKA‐31 Improves Cardiac Function and Blood Pressure in Type 2 Diabetic Goto‐Kakizaki Rats

Abstract
No abstract available
Funding Information
  • Canadian Institutes of Health Research (MOP‐142467)
  • Natural Sciences and Engineering Research Council of Canada (RGPIN‐2017‐04116)
  • National Institutes of Health (R21 NS101876)